Clinical Research Directory
Browse clinical research sites, groups, and studies.
Use of Immune Checkpoint Inhibitors in Patients With Advanced Hepatocellular Carcinoma : Efficacy and Outcomes
Sponsor: Ahmed Karam Helmy
Summary
the Objectives of this study are: • Primary Objective: To prospectively evaluate overall survival (OS), ICI-specific survival (OS-ICI), and progression-free survival (PFS) in patients with advanced HCC treated with immune checkpoint inhibitors. the main question it aims to answer is: What are the clinical outcomes (overall survival, progression-free survival, and OS-ICIs) of immune checkpoint inhibitor therapy in patients with advanced hepatocellular carcinoma? Participants already taking immune checkpoint inhibitors as part of their regular medical care.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
75
Start Date
2026-01-01
Completion Date
2027-11-01
Last Updated
2026-01-06
Healthy Volunteers
No
Conditions
Locations (2)
Sohag university hospitals
Sohag, Sohag Governorate, Egypt
sSohag oncology centre
Sohag, Sohag Governorate, Egypt